Neuromedin U receptor 2

From WikiMD's WELLNESSPEDIA

Neuromedin U receptor 2 (NMUR2) is a protein that in humans is encoded by the NMUR2 gene. This receptor is part of the G protein-coupled receptor (GPCR) family, which plays a critical role in signal transduction pathways. NMUR2 specifically binds to neuromedin U, a neuropeptide with various physiological functions, including the regulation of smooth muscle contraction, blood pressure, immune response, and feeding behavior.

Function[edit]

NMUR2 is predominantly expressed in the peripheral nervous system and some parts of the central nervous system, with high levels in the spinal cord and gastrointestinal tract. This receptor mediates the effects of neuromedin U, which is involved in a wide range of biological functions. For instance, neuromedin U has been shown to play a role in the regulation of stress responses, energy homeostasis, and pain perception. The activation of NMUR2 by neuromedin U can lead to various intracellular responses, including the activation of phospholipase C, resulting in the production of inositol trisphosphate (IP3) and diacylglycerol (DAG), and the release of calcium ions from intracellular stores.

Clinical Significance[edit]

Research has suggested that NMUR2 and its ligand neuromedin U may be involved in the pathophysiology of several diseases, including obesity, diabetes, and inflammatory diseases. The receptor's role in regulating feeding behavior and energy homeostasis makes it a potential target for the development of drugs to treat obesity and metabolic disorders. Additionally, because of its involvement in pain perception, NMUR2 could also be a target for novel analgesic drugs.

Genomics[edit]

The NMUR2 gene is located on human chromosome 5q33. This gene encodes a receptor that is composed of 389 amino acids and is structurally characterized by seven transmembrane domains, a hallmark of G protein-coupled receptors. The gene and its encoded protein share structural similarities with the neuromedin U receptor 1 (NMUR1), although they have distinct tissue distributions and physiological roles.

Pharmacology[edit]

The pharmacological characterization of NMUR2 has been the subject of ongoing research. Agonists and antagonists for NMUR2 are being developed and tested for their potential therapeutic applications. Understanding the specific interactions between neuromedin U and NMUR2, as well as the signal transduction pathways activated by this receptor, is crucial for the development of drugs targeting NMUR2-related pathways.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.